European Heart Journal Advance Access published online on December 17, 2004
European Heart Journal, doi:10.1093/eurheartj/ehi079
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Epidemiology and Public Health, Royal College of Surgeons in Ireland, Dublin 2, Ireland
* To whom correspondence should be addressed. Aims Systematic registration of data from clinical practice is important for clinical care, local, national and international registries, and audit. Data to be collected for these different purposes should be harmonized. Therefore, during Ireland's Presidency of the European Union (EU) (January to June 2004), the Department of Health and Children worked with the European Society of Cardiology, the Irish Cardiac Society, and the European Commission to develop data standards for clinical cardiology. The Cardiology Audit and Registration Data Standards (CARDS) Project aimed to agree standards for three modules of cardiovascular health information systems: acute coronary syndromes (ACS), percutaneous coronary interventions (PCI), and clinical electrophysiology (pacemakers, implantable cardioverter defibrillators, and ablation procedures). Methods and results Data items from existing registries and surveys were reviewed to derive draft data standards (variables, coding, and definitions). Variables common to the three modules include demographics, risk factors, medication, and discharge and follow-up data. Modules about a procedure contain variables on the lesion, the device, and medication during the procedure. The ACS module includes presenting symptoms, reperfusion and acute treatments, and procedures in hospital and at follow-up. Conclusions The data standards were discussed and adopted at a conference involving EU member states in Cork, Ireland, in May 2004. After a pilot study, the standards will be disseminated to stakeholders throughout Europe.
Special article
The Cardiology Audit and Registration Data Standards (CARDS), European data standards for clinical cardiology practice
2 Cardiology Departments, Cork University Hospital, Cork and Mater Misericordiae University Hospital, Dublin, Ireland
3 Cardiology Department, Hospital Universitario de Getafe, Madrid, Spain
4 Cardiology Department, Ludwigshafen, Germany
5 Uppsala Clinical Research Centre, University Hospital Uppsala, Sweden
6 Cardiology Department, Cork University Hospital, Cork, Ireland
7 Chief Department of Cardiology, Thoraxcenter, Erasmus University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands
Maarten L. Simoons, E-mail: m.simoons{at}erasmusmc.nl
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Lagerqvist, J. Carlsson, O. Frobert, J. Lindback, F. Schersten, U. Stenestrand, S. K. James, and for the Swedish Coronary Angiography and Angioplas Stent Thrombosis in Sweden: A Report From the Swedish Coronary Angiography and Angioplasty Registry Circ Cardiovasc Interv, October 1, 2009; 2(5): 401 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. James, U. Stenestrand, J. Lindback, J. Carlsson, F. Schersten, T. Nilsson, L. Wallentin, B. Lagerqvist, and the SCAAR Study Group Long-Term Safety and Efficacy of Drug-Eluting versus Bare-Metal Stents in Sweden N. Engl. J. Med., May 7, 2009; 360(19): 1933 - 1945. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Palmerini, A. Marzocchi, C. Tamburino, I. Sheiban, M. Margheri, G. Vecchi, G. Sangiorgi, A. Santarelli, A. Bartorelli, C. Briguori, et al. Impact of Bifurcation Technique on 2-Year Clinical Outcomes in 773 Patients With Distal Unprotected Left Main Coronary Artery Stenosis Treated With Drug-Eluting Stents Circ Cardiovasc Interv, December 1, 2008; 1(3): 185 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. F M Weston Performance indicators in acute myocardial infarction: a proposal for the future assessment of good quality care Heart, November 1, 2008; 94(11): 1397 - 1401. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sousa, A. S. Uva, F. Pinto, and on behalf of the Investigators of PCI Registry of Risk-adjustment model in health outcomes evaluation: a contribution to strengthen assessment towards quality improvement in interventional cardiology Int. J. Qual. Health Care, October 1, 2008; 20(5): 324 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, J.-P. Bassand, C. W. Hamm, D. Ardissino, E. Boersma, A. Budaj, F. Fernandez-Aviles, K. A.A. Fox, D. Hasdai, E. M. Ohman, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology Eur. Heart J., July 1, 2007; 28(13): 1598 - 1660. [Full Text] [PDF]
|
|
|
|
|
|
B. Lagerqvist, S. K. James, U. Stenestrand, J. Lindback, T. Nilsson, L. Wallentin, and the SCAAR Study Group Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden N. Engl. J. Med., March 8, 2007; 356(10): 1009 - 1019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Escaned, L. Ryden, J. L. Zamorano, P. Poole-Wilson, V. Fuster, A. Gitt, F. Fernandez-Aviles, W. Scholte op Reimer, E. de Teresa, L. Alonso-Pulpon, et al. Trends and contexts in European cardiology practice for the next 15 years: The Madrid Declaration: a report from the European Conference on the Future of Cardiology, Madrid, 2-3 June 2006 Eur. Heart J., March 1, 2007; 28(5): 634 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tendera How much does Europe invest in the treatment of cardiovascular diseases? Eur. Heart J., July 1, 2006; 27(13): 1521 - 1522. [Full Text] [PDF]
|
|
|
|
|
|
J.-P. Bassand, N. Danchin, G. Filippatos, A. Gitt, C. Hamm, S. Silber, M. Tubaro, and F. Weidinger Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of Cardiology Eur. Heart J., December 2, 2005; 26(24): 2733 - 2741. [Abstract] [Full Text] [PDF]
|
|